Under deal terms, GSK will give Vesalius Therapeutics $80 million in upfront and equity payments to identify treatments for ...

GSK has licensed a small molecule for Parkinson's and is teaming up on additional targets for the disease and another ...

GSK is paying $80 million to ink a multi-target neurodegenerative pact with Flagship-founded Vesalius Therapeutics that ...

GSK’s Trelegy, a treatment for chronic obstructive pulmonary disease (COPD), aimed to address a gap in the market with its ...

Though GSK has put considerable effort into developing pharmacological treatments for gynecological cancers—including Zejula, ...

The last dates for submission of written comments and counter-comments on the paper have been extended up to November 19 and November 26, respectively ...

Shalini Kumar has joined Kenvue as Head - Consumer Experience. Shalini was earlier with Halenon as Area Media Lead for ...

A total of 739 deals were completed so far this year representing a decrease of just under 21 per cent compared to last year.

With a rich background in brand positioning, Laura brings a wealth of strategic experience partnering with renowned organizations including Keurig Dr Pepper, Nestle, American Cancer Society, Merck, ...

Brings Strong Background in Pharmaceutical Manufacturing Operations and Finance to Help Drive Performance and ProductivityJackie Klecker Named ...

SLE is a chronic and complex heterogeneous autoimmune disease in which the immune system dysfunctions and inappropriately ...

Chancellor of the Exchequer Rachel Reeves is promising " more pounds in pockets " despite being set to deliver tax rises and ...